Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: A key factor to the unrestrained cell proliferation?
Open Access
- 27 August 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 81 (2) , 232-236
- https://doi.org/10.1038/sj.bjc.6690682
Abstract
The hydrolysis of sphingomyelin generates key molecules regulating cell growth and inducing apoptosis. Data from animal cancer models support an inhibitory role for this pathway in the malignant transformation of the colonic mucosa. In the intestinal tract, a sphingomyelinase with an optimum alkaline pH has been identified. We recently found that the activity of alkaline sphingomyelinase is significantly decreased in colorectal adenocarcinomas, indicating a potential anticarcinogenic role of this enzyme. To further examine whether the reduction of sphingomyelinase is present already in the premalignant state of neoplastic transformation, we measured sphingomyelinase activities in patients with familial adenomatous polyposis (FAP) and in sporadic colorectal tubulovillous adenomas. Tissue samples were taken from adenomas and surrounding macroscopically normal mucosa from 11 FAP patients operated with ileorectal anastomosis, from three FAP patients with intact colon, from 13 patients with sporadic colorectal adenomas and from 12 controls. Activities of acid, neutral and alkaline sphingomyelinase were measured together with alkaline phosphatase. In FAP adenoma tissue, alkaline sphingomyelinase activity was reduced by 90% compared to controls (P < 0.0001), acid sphingomyelinase by 66% (P < 0.01) and neutral sphingomyelinase by 54% (P < 0.05). Similar reductions were found in the surrounding mucosa. In sporadic adenoma tissue, only alkaline sphingomyelinase was reduced significantly, by 57% (P < 0.05). Alkaline phosphatase was not changed in FAP adenomas, but decreased in the sporadic adenomas. We conclude that the markedly reduced levels of alkaline sphingomyelinase activities in FAP adenomas and in the surrounding mucosa may be a pathogenic factor that can lead to unrestrained cell proliferation and neoplastic transformation.Keywords
This publication has 33 references indexed in Scilit:
- Distribution of alkaline sphingomyelinase activity in human beings and animalsDigestive Diseases and Sciences, 1996
- Identification of an alkaline sphingomyelinase activity in human bileBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Characterization of malignant colon tumors with31p nuclear magnetic resonance phospholipid and phosphatic metabolite profilesCancer, 1995
- Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characteristicsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipidsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP)Human Molecular Genetics, 1992
- Identification and characterization of the familial adenomatous polyposis coli geneCell, 1991
- Sphingomyelin and derivatives as cellular signalsProgress in Lipid Research, 1991
- Magnesium-dependent sphingomyelinaseBiochemical and Biophysical Research Communications, 1976
- The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tractBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969